BlackRock Fund Advisors’s Cumberland Pharmaceuticals CPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$182K Buy
33,106
+1,363
+4% +$7.11K ﹤0.01% 3447
2016
Q3
$159K Sell
31,743
-99
-0.3% -$466 ﹤0.01% 3524
2016
Q2
$143K Sell
31,842
-622
-2% -$2.85K ﹤0.01% 3566
2016
Q1
$146K Sell
32,464
-2,692
-8% -$12.8K ﹤0.01% 3565
2015
Q4
$185K Buy
35,156
+1,104
+3% +$6.29K ﹤0.01% 3560
2015
Q3
$196K Sell
34,052
-900
-3% -$5.61K ﹤0.01% 3472
2015
Q2
$250K Sell
34,952
-6,916
-17% -$48.1K ﹤0.01% 3436
2015
Q1
$279K Sell
41,868
-2,832
-6% -$17.7K ﹤0.01% 3396
2014
Q4
$267K Buy
44,700
+3,186
+8% +$16.4K ﹤0.01% 3399
2014
Q3
$205K Sell
41,514
-3,009
-7% -$14.6K ﹤0.01% 3454
2014
Q2
$200K Buy
44,523
+1,272
+3% +$5.68K ﹤0.01% 3489
2014
Q1
$195K Buy
43,251
+5,247
+14% +$25K ﹤0.01% 3467
2013
Q4
$194K Buy
38,004
+1,590
+4% +$7.76K ﹤0.01% 3451
2013
Q3
$165K Buy
36,414
+2,862
+9% +$14.2K ﹤0.01% 3433
2013
Q2
$171K Buy
+33,552
New +$167K ﹤0.01% 3375

Other funds holding CPIX

BlackRock Fund Advisors's CPIX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Cumberland Pharmaceuticals (CPIX) stake by 4.3% in Q4 2016, buying an estimated $7.11K and bringing the position to 33,106 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #3447.

BlackRock Fund Advisors first reported a position in CPIX in Q2 2013 and has held it in 15 quarters since. The position peaked at $279K in Q1 2015. 41 funds tracked by Wall St. Rank hold CPIX as of Q4 2016.

  • BlackRock Fund Advisors held 33,106 shares of Cumberland Pharmaceuticals worth $182K as of Q4 2016.
  • BlackRock Fund Advisors bought 1,363 Cumberland Pharmaceuticals shares in Q4 2016, an estimated $7.11K.
  • Cumberland Pharmaceuticals made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3447 holding.
  • BlackRock Fund Advisors first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Cumberland Pharmaceuticals position peaked at $279K in Q1 2015.
  • 41 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.